About Perfuze
Perfuze is a company based in Galway (Ireland) founded in 2018.. Perfuze has raised $53.17 million across 5 funding rounds from investors including EQT, European Commission and Enterprise Ireland. Perfuze offers products and services including Millipede 088 Catheter. Perfuze operates in a competitive market with competitors including Conformal Medical, MIVI Neuroscience, MicroTransponder, Wallaby Medical and Enspire DBS Therapy, among others.
- Headquarter Galway, Ireland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Perfuze Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$53.17 M (USD)
in 5 rounds
-
Latest Funding Round
$23.98 M (USD), Series A
Mar 13, 2025
-
Investors
EQT
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Perfuze
Perfuze offers a comprehensive portfolio of products and services, including Millipede 088 Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Catheter for removing clots in ischemic stroke patients.
Funding Insights of Perfuze
Perfuze has successfully raised a total of $53.17M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $23.98 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $24.0M
-
First Round
First Round
(29 Jan 2019)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series A - Perfuze | Valuation | Earlybird , EQT |
|
| Feb, 2022 | Amount | Series A - Perfuze | Valuation | Life Sciences Partners , Seroba Lifesciences | |
| Aug, 2019 | Amount | Grant - Perfuze | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Perfuze
Perfuze has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT, European Commission and Enterprise Ireland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Founded Year | Domain | Location | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Founded Year | Domain | Location | |
|
Seroba Lifesciences is focused on life sciences venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Perfuze
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Perfuze
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perfuze Comparisons
Competitors of Perfuze
Perfuze operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, MIVI Neuroscience, MicroTransponder, Wallaby Medical and Enspire DBS Therapy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Stroke prevention device for atrial fibrillation patients is developed.
|
|
| domain | founded_year | HQ Location |
Catheters and devices for acute ischemic stroke treatment are developed.
|
|
| domain | founded_year | HQ Location |
Neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation
|
|
| domain | founded_year | HQ Location |
A medical device for stroke treatment is developed.
|
|
| domain | founded_year | HQ Location |
Stroke recovery therapy is developed via deep brain stimulation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Perfuze
Frequently Asked Questions about Perfuze
When was Perfuze founded?
Perfuze was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Perfuze located?
Perfuze is headquartered in Galway, Ireland.
Is Perfuze a funded company?
Perfuze is a funded company, having raised a total of $53.17M across 5 funding rounds to date. The company's 1st funding round was a Grant of $2.75M, raised on Jan 29, 2019.
What does Perfuze do?
Perfuze was founded in 2018 in Galway, Ireland, within the medical devices sector. Catheter technology has been developed for acute ischemic stroke intervention, targeting blockages in cerebral blood flow. Operations focus on healthcare innovations that address stroke-related impairments. The technology is designed to support timely treatment and minimize long-term physical disabilities in affected patients. The companys domain is perfuze.com.
Who are the top competitors of Perfuze?
Perfuze's top competitors include MicroTransponder, Conformal Medical and MIVI Neuroscience.
What products or services does Perfuze offer?
Perfuze offers Millipede 088 Catheter.
Who are Perfuze's investors?
Perfuze has 9 investors. Key investors include EQT, European Commission, Enterprise Ireland, European Union, and Life Sciences Partners.